Search for:
Search for:
Healthcare Professionals
Publications
News
Español
Contact
Magazine
Radio
Get Educated
What is MS?
A chronic neurological disorder that affects the central nervous system, comprised of the brain...
More Details
Educational Materials
Common Questions
Lending Library
Symptoms
Treatment Options
Additional Resources
Research
MS Awareness Month
Donate
Get Help
Health & Wellness Program
Get educational materials and referrals, as well as the opportunity to participate in various...
Learn More
Grants & Programs
Awareness Campaigns
Support Groups
Events
Lending Library
Additional Resources
Get Involved
MS Awareness Month
An annual, nationwide campaign with goals to promote an understanding of MS, and to assist those...
Learn More
Advocacy
Buy from Partners
Volunteer
Businesses
MS Research Trials
Outreach
Awareness Campaigns
Host an Event
Events
Test Flyout
lorem ipsum dolor sit lorem ipsum dolor sit lorem ipsum dolor sit lorem ipsum dolor sit lorem...
Learn More
Events Calendar
Health & Wellness
Fundraisers
Support
Web & Teleconferences
MS Education
Host an Event
About Us
Programs & Grants
More Details
Overview
Press Room
Leadership
Financial Statements
Our Mission
Careers at MS Focus
Affiliations
News & Features
MS Focus At Sea
MS Focus At Sea offers educational programs, opportunities to meet old and new friends, and adventures for every...
/Events/MSF-Events/MSFocus-Cruise-For-A-Cause
Brighter Tomorrow Grant
The Brighter Tomorrow Grant allows MS Focus to makes dreams come true for people with MS across...
/Get-Help/MSF-Programs-Grants/Brighter-Tomorrow-Grant
Shop
Privacy
Terms of Use
Site Map
Noncontrast MRI is effective in monitoring MS patients
March 14, 2019
Brain MRI without contrast agent is just as effective as the contrast-enhanced approach for monitoring disease progression in patients with multiple sclerosis, according to a new study. The findings support the possibility that contrast enhancement can be omitted from routine follow-up scans.
MRI with the administration of gadolinium-based contrast material is widely considered obligatory for follow-up scans of patients with MS. Gadolinium, a heavy metal, enhances the images and helps provide important diagnostic information, but it leads to both prolonged scan times and increased costs. There is also evidence that some of the metal remains in the body after contrast administration, although the long-term clinical effect of these deposits is unclear.
Advances in noncontrast MRI image acquisition and post-processing technology, along with the increasing availability of powerful 3T MRI machines, have raised the possibility that nonenhanced scans could have a role in MS follow-up imaging. To learn more, researchers at the Technische Universität München in Munich, Germany, used MRI to assess new or enlarged lesions in 359 patients with MS.
Of 507 follow-up scans, 264 showed interval progression, defined by as at least one new or unequivocally enlarged lesion on follow-up MRI scans. There were a total of 1,992 new or enlarged lesions. With 3T MRI, the assessment of interval progression did not differ significantly between the contrast-enhanced and nonenhanced images.
The researchers credited an image subtraction pipeline developed and researched at his facility for the powerful sensitivity of the noncontrast MRI in detecting newly occurring lesions. The approach combines 3-D MRI and subtraction techniques, which cancel out unchanged areas in the follow-up image, substantially improving visualization of new or enlarging white matter lesions. This combination of 3-D sequences and subtraction techniques is key to improving sensitivity for detecting newly occurred lesions.
The study was published in the journal
Radiology
.
MS Focus Lending Library
Books, DVDs, and CDs are available for loan, by mail across the United States.
Learn more